GlycoMimetics, Inc. (GLYC) Dividend History

GlycoMimetics, Inc. (GLYC) is a biopharmaceutical company focused on developing innovative glycomimetic drugs to treat cancers, infectious diseases, and inflammatory conditions. The company's research emphasizes targeting selectin proteins and other carbohydrate-mediated pathways to improve patient outcomes.

9708 Medical Center Drive, Rockville, MD, 20850
Phone: 240-243-1201
Website:

Dividend History

GlycoMimetics, Inc. currently does not pay dividends

Company News

Dividend data last updated 06/07/2025 16:16:25 UTC